Results 141 to 150 of about 22,846 (183)
Some of the next articles are maybe not open access.

Strategies for the analysis of in vitro radiation sensitivity and prediction of interaction with potential radiation modifying agents

International Journal of Radiation Biology, 2010
To better predict radiation-drug interactions in in vitro model systems, thorough assessment of the effects of in vitro exposure is required. The aim of this article is to show that both clonogenic capacity and cellular proliferation, which represent important different elements of tumour conduct, can be considered when assessing in vitro radio ...
Luttjeboer, M.   +7 more
openaire   +3 more sources

Radiation sensitizing agents in clinical radiation and chemotherapy.

Journal of medicine, 1980
Patients with bronchogenic carcinoma or with advanced pediatric solid tumours were treated with various radiation therapy schedules alone or with a new alkylating carbamate: AB 132. Drug therapy appeared to potentiate radiation therapy results without significant toxicity except for certain neurologic symptoms (myasthenia, nightmares, disturbances of ...
J L, Ambrus   +3 more
openaire   +1 more source

Combined radiation-protective and radiation-sensitizing agents III: Radiosensitization by misonidazole as a function of concentrations of endogenous glutathione or exogenous thiols

International Journal of Radiation Oncology*Biology*Physics, 1986
Radiosensitization of V79 Chinese hamster fibroblasts by 0.5 mM misonidazole is a smooth function of endogenous glutathione (GSH) levels as modulated upwards by pre-incubation in medium containing cysteamine, or downwards by pre-incubation in medium containing buthionine sulfoximine.
C J, Koch, C C, Stobbe, K A, Baer
openaire   +2 more sources

Cross sensitivity to mono- and bifunctional alkylating agents of three radiation-sensitiveSaccharomyces mutants

Biophysik, 1973
The inactivation of three radiation-sensitive haploidSaccharomyces mutants, as well as that of corresponding homozygous diploid mutants, following treatment with the bifunctional alkylating agent diepoxybutane (DEB) or the monofunctional alkylating agents methylmethane-sulfonate (MMS) or methylnitrosoguanidine (MNG) was investigated.
W, Laskawski, E, Lehmann-Brauns
openaire   +2 more sources

Radiation sensitizing and radiation protective agents in experimental radiation therapy.

Journal of medicine, 1989
It appears that AB-132 potentiates radiation effects, and the local application of AET (MEG) protects the intestinal tract, the bladder and the skin against radiation toxicity. Combined use of selective radiation sensitizing and protecting agents may be considered for clinical studies.
J L, Ambrus   +4 more
openaire   +1 more source

Modulation of Alkylating Agents by Radiation Sensitizers— Clinical Aspects

1986
Alkylating agents are among the most commonly used anticancer agents. They have the widest spectrum of antitumor activity of any class of agents. Individual alkylating agents usually are not cross resistant, since the mechanisms and sites of alkylation of each agent may differ considerably.
openaire   +1 more source

The Effect of Radiation Sensitizing and Protective Agents on the Post-irradiation Synthesis of DNA by Membrane Complexes ofEscherichia Coli B/r

International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1973
SummaryMeasurements were made of the synthesis of DNA by membrane-DNA complexes extracted from Escherichia coli B/r that had been sensitized to or protected against the lethal effects of ionizing radiation by irradiating the bacteria in the presence of indane trione, acriflavine, thiourea, or β-mercaptoethanol. Pre-irradiation treatment of the bacteria
W A, Cramp, H N, Fraval, J, Collins
openaire   +2 more sources

Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.

Cancer research, 1981
The influence of the radiosensitizer misonidazole on the effectiveness of several alkylating agents and cis-platinum against advanced solid murine tumors was investigated. Tumor regrowth delay, frequency of tumor regressions, and animal life span were used to evaluate misonidazole in combination with cyclophosphamide, L-phenylalanine mustard, 1-(2 ...
J J, Clement   +4 more
openaire   +1 more source

The Effect on the K m for Radiosensitization at 0 degrees C of Thiol Depletion by Diethylmaleate Pretreatment: Quantitative Differences Found Using the Radiation Sensitizing Agent Misonidazole or Oxygen

Radiation Research, 1984
Pretreatment of V79- WNRE cells with 150 microM diethylmaleate for 1 hr at 37 degrees C caused a decrease in intracellular glutathione levels to approximately 10-15% of control levels (0.5 vs 5.0 nmol/10(6) cells). The cells could be washed free of diethylmaleate and held at 0 degree C for several hours without toxicity and with no increase in ...
C J, Koch, C C, Stobbe, E A, Bump
openaire   +2 more sources

Combined Radiation-Protective and Radiation-Sensitizing Agents: II. Radiosensitivity of Hypoxic or Aerobic Chinese Hamster Fibroblasts in the Presence of Cysteamine and Misonidazole: Implications for the "Oxygen Effect" (With Appendix on Calculation of Dose-Modifying Factors)

Radiation Research, 1981
Experiments have been done to test whether a hypoxic cell radiosensitizing agent (misonidazole) can be combined with a radioprotecting agent (cysteamine) to equalize partially the radiation response of hypoxic and aerobic mammalian cells in tissue culture.
C J, Koch, R L, Howell
openaire   +2 more sources

Home - About - Disclaimer - Privacy